Why the study?
With the increasing availability of consumer-grade rhythm monitoring devices, identifying their strengths and limitations in clinical telemedicine is of vital importance.
This case report highlights a specific limitation of consumer-grade smartwatch ECGs in identifying atrial flutter morphology and proposes a practical solution.
Case report of Apple Watch ECG use; leaves open reliability questions for AF detection in telemedicine.
The Apple Watch (Apple Inc, Cupertino, CA) is a class II medical device that features an electrocardiogram (ECG) monitoring feature that is primarily used for the detection of atrial fibrillation.1 With the increasing availability of the Apple Watch and other consumer-grade rhythm monitoring devices, identifying the strengths and limitations of utilizing these devices in the clinical setting, particularly during an era of increasing telemedicine, is of vital importance. Here we present a case demonstrating a specific limitation of the Apple Watch in the identification of atrial tachyarrhythmias and provide a solution to resolve this issue.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: